Yasuhiko Suzuki Selected Research

ribosomal protein S12

12/2020

Molecular analysis of streptomycin-resistance associating genes in Mycobacterium tuberculosis isolates from Nepal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiko Suzuki Research Topics

Disease

27	Tuberculosis (Tuberculoses) 01/2022 - 02/2002
20	Infections 12/2020 - 02/2002
13	Neoplasms (Cancer) 01/2022 - 12/2004
12	Leprosy (Hansen's Disease) 12/2021 - 09/2006
8	Disease Progression 02/2021 - 01/2012
6	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 11/2012
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2016
4	Persistent Infection 12/2021 - 07/2014
4	Deltaretrovirus Infections (BLV Infection) 01/2021 - 07/2013
3	Hypoxia (Hypoxemia) 01/2022 - 09/2011
3	Paratuberculosis (Johne's Disease) 01/2020 - 01/2018
3	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
3	Pulmonary Tuberculosis 10/2019 - 11/2015
3	Salmonella Infections (Salmonellosis) 01/2019 - 08/2015
3	Latent Tuberculosis 12/2016 - 01/2012
2	Abscess 07/2022 - 07/2020
2	Cattle Diseases (Bovine Diseases) 01/2022 - 07/2014
2	Communicable Diseases (Infectious Diseases) 12/2021 - 07/2017
2	Chronic Disease (Chronic Diseases) 10/2019 - 01/2017
2	Inflammation (Inflammations) 02/2019 - 07/2011
2	Virus Diseases (Viral Diseases) 01/2019 - 06/2014
2	Campylobacter Infections (Campylobacter Infection) 10/2016 - 08/2015
2	Leptospirosis 09/2016 - 04/2016
2	Atherosclerosis 12/2011 - 09/2011
1	Gram-Negative Bacterial Infections 01/2022
1	Extensively Drug-Resistant Tuberculosis 01/2021
1	Horse Diseases (Horse Disease) 01/2020
1	Lung Injury 01/2020
1	Ulcerative Colitis 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2022 - 09/2006
12	AntibodiesIBA 01/2022 - 01/2012
8	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 10/2008
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2007
7	LigandsIBA 02/2021 - 01/2014
6	B7-H1 AntigenIBA 01/2022 - 01/2014
6	Ofloxacin (Ofloxacine)FDA LinkGeneric 12/2021 - 10/2008
6	QuinolonesIBA 12/2019 - 02/2011
5	Monoclonal AntibodiesIBA 02/2021 - 01/2012
5	FluoroquinolonesIBA 12/2019 - 01/2012
4	Streptomycin (Streptomycin Sulfate)FDA Link 09/2021 - 02/2007
4	Biological ProductsIBA 01/2021 - 07/2013
4	Dinoprostone (PGE2)FDA Link 12/2020 - 01/2018
4	16S Ribosomal RNAIBA 12/2020 - 07/2012
4	AntigensIBA 01/2017 - 01/2014
4	OsteopontinIBA 12/2016 - 01/2012
3	Antitubercular AgentsIBA 01/2022 - 01/2020
3	CytokinesIBA 01/2021 - 12/2016
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 09/2016
3	Pyrazinamide FDA LinkGeneric 01/2018 - 02/2002
3	Immunoglobulin G (IgG)IBA 01/2017 - 01/2012
3	EnzymesIBA 12/2016 - 06/2014
3	ImmunosorbentsIBA 12/2016 - 06/2014
3	sitafloxacinIBA 10/2016 - 01/2012
2	CopperIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2022 - 01/2020
2	Isoniazid (Ftivazide)FDA LinkGeneric 05/2021 - 01/2020
2	MethyltransferasesIBA 12/2020 - 01/2018
2	WQ-3810IBA 01/2020 - 12/2019
2	DNA GyraseIBA 12/2019 - 01/2019
2	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 01/2019 - 09/2016
2	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2014
2	Blocking AntibodiesIBA 01/2018 - 01/2017
2	lipoarabinomannan (LAM)IBA 01/2017 - 01/2015
2	GlycolipidsIBA 01/2015 - 01/2012
2	Immunoglobulin A (IgA)IBA 01/2015 - 01/2012
2	Messenger RNA (mRNA)IBA 09/2011 - 04/2007
2	OligonucleotidesIBA 04/2011 - 09/2006
2	Rifampin (Rifampicin)FDA LinkGeneric 11/2010 - 10/2008
2	Nucleic AcidsIBA 07/2010 - 04/2008
1	Thymidylate SynthaseIBA 01/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2022
1	Tigecycline (Tygacil)FDA Link 01/2022
1	4,6-dinitro-o-cresol (DNOC)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-2 (IL2)IBA 12/2021
1	AntitoxinsIBA 09/2021
1	vesatolimodIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Colistin (Coly-Mycin)FDA Link 12/2020
1	Amikacin (A.M.K)FDA LinkGeneric 12/2020
1	8-methylguanosineIBA 12/2020
1	ribosomal protein S12IBA 12/2020
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 07/2020
1	Cefoperazone (Cefoperazone Sodium)FDA Link 07/2020
1	AgarIBA 07/2020
1	Charcoal (Charbon)IBA 07/2020
1	SteroidsIBA 01/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2019
1	Cytochrome P-450 CYP2C9IBA 01/2019

Therapy/Procedure

10	Therapeutics 01/2022 - 12/2007
7	Immunotherapy 02/2021 - 12/2007
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020